News
Stocktwits on MSN43m
Sarepta Pauses DMD Gene Therapy Trial After Second Death; Retail Traders Brush Off RiskRetail investor chatter around Sarepta Therapeutics surged on Sunday after the company announced it had suspended shipments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback